| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/15/1999 | WO1999034669A1 Cloning using donor nuclei from differentiated fetal and adult cells |
| 07/15/1999 | WO1999029729A3 Antagonists of neuropilin receptor function and use thereof |
| 07/15/1999 | WO1999028466A8 Compositions and methods of use of het |
| 07/15/1999 | WO1999025823A3 Recombinant allergen with reduced enzymatic activity |
| 07/15/1999 | WO1999025375A8 DIRECT CYTOTOXIC ACTIVITY BY ANTI-hCG MONOCLONAL ANTIBODIES |
| 07/15/1999 | WO1999024391B1 Radio-opaque polymer biomaterials |
| 07/15/1999 | WO1999023867A3 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 07/15/1999 | WO1999021992A9 Nucleic acid molecules encoding a glutamate receptor |
| 07/15/1999 | WO1999021582A3 Application of tnf antagonists as medicaments for treating septic diseases |
| 07/15/1999 | WO1999018990A9 The il-1 receptor related protein 3 (il-1rrp3) |
| 07/15/1999 | WO1999018216A9 Chimeric vaccine against tick-borne encephalitis virus |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | WO1998053066A9 Smad2 phosphorylation and interaction with smad4 |
| 07/15/1999 | WO1998042855A9 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 07/15/1999 | DE19801154A1 Preparation of pure recombinant thyroid stimulating hormone receptor useful for detection of autoantibodies in human serum |
| 07/15/1999 | DE19801153A1 Selection of a ribozymes useful for, e.g. inhibiting gene expression and improving nuclease resistance |
| 07/15/1999 | CA2365742A1 Formulations for amylin agonist peptides |
| 07/15/1999 | CA2351624A1 Compounds and methods for modulating tissue permeability |
| 07/15/1999 | CA2324972A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | CA2321972A1 Gene therapy of tumors using non-viral delivery system |
| 07/15/1999 | CA2318435A1 Human fk506 binding proteins |
| 07/15/1999 | CA2318369A1 Recombinant, active caspases and uses thereof |
| 07/15/1999 | CA2317898A1 Human vps35/mem3-related protein |
| 07/15/1999 | CA2317739A1 Method for administering aspb28-human insulin |
| 07/15/1999 | CA2317733A1 Method for administering monomeric insulin analogs |
| 07/15/1999 | CA2317724A1 Methods and compositions for desensitisation |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2317674A1 Methods and compositions for treating and diagnosing insulin related disorders |
| 07/15/1999 | CA2317494A1 Cloning using donor nuclei from differentiated fetal and adult cells |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2317057A1 Apoptosis inducing molecule ii |
| 07/15/1999 | CA2317020A1 Non-identical genes and their application in improved molecular adjuvan ts |
| 07/15/1999 | CA2317010A1 Topical ophthalmic preparations containing immunosuppressive agents |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2315880A1 Streptococcal heat shock proteins of the hsp60 family |
| 07/15/1999 | CA2315265A1 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928790A1 Thiazole derivatives |
| 07/14/1999 | EP0928786A1 Angiogenesis inhibitor |
| 07/14/1999 | EP0928419A1 Compositions and methods for modulating type i interleukin-1 receptor expression |
| 07/14/1999 | EP0928340A1 Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
| 07/14/1999 | EP0928337A1 A human protein tyrosine kinase |
| 07/14/1999 | EP0928336A1 Chaperone fragments |
| 07/14/1999 | EP0928335A2 METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CpG DINUCLEOSIDES |
| 07/14/1999 | EP0928328A1 Methods for culturing cells |
| 07/14/1999 | EP0928306A1 Antiviral linear polymers |
| 07/14/1999 | EP0928294A1 Method and apparatus for preparing an acellular red blood cell substitute |
| 07/14/1999 | EP0928293A1 Il-6 and il-6-receptor derived peptides having il-6 antagonistic or agonistic activity |
| 07/14/1999 | EP0928292A1 Polypeptides mimicking the activity of human erythropoietin |
| 07/14/1999 | EP0928291A1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase |
| 07/14/1999 | EP0928290A1 Oligoribonucleotides and ribonucleases for cleaving rna |
| 07/14/1999 | EP0928203A1 Gene therapy for inhibition of angiogenesis |
| 07/14/1999 | EP0928202A1 Non-invasive administration of adeno-associated viral vectors |
| 07/14/1999 | EP0928197A1 Use of proteins as agents against autoimmune diseases |
| 07/14/1999 | EP0759079B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1-BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel-III) |
| 07/14/1999 | EP0754234B1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1 BETA CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICE rel-II) |
| 07/14/1999 | EP0581856B1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 07/14/1999 | EP0574414B1 LIGAND GROWTH FACTORS THAT BIND TO THE erbB-2 RECEPTOR PROTEIN AND INDUCE CELLULAR RESPONSES |
| 07/14/1999 | EP0553198B1 Regulation of immunoglobulin production by interleukin-9 |
| 07/14/1999 | EP0531434B1 Improved pseudomonas exotoxins of low animal toxicity and high cytocidal activity |
| 07/14/1999 | CN1222935A Compounds and method for immunotherapy and immunodiagnosis of prostate cancer |
| 07/14/1999 | CN1222918A Cell adhesion inhibiting compounds |
| 07/14/1999 | CN1222917A Novel protein and process for producing the same |
| 07/14/1999 | CN1222859A Therapeutic uses of BPI protein products in humans with hemorrhage due to trauma |
| 07/14/1999 | CN1222858A Antithrombotic materials and methods |
| 07/14/1999 | CN1222857A Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid |
| 07/14/1999 | CN1222392A Compound injection for curing ischemic eye disease |
| 07/14/1999 | CN1222391A Anti-senility essence |
| 07/14/1999 | CN1044121C Method for isolating coagulation factors VIII complex |
| 07/14/1999 | CN1044117C Compound for inhibition of HIV protease, its preparing method and its drug use |
| 07/14/1999 | CN1044089C Medicine composition with enantiomerically pure beta-D-dioxolane nucleosides as active component |
| 07/13/1999 | US5922878 Amino acid derivatives, processes for preparing them and pharmaceutical compositions containing these compounds |
| 07/13/1999 | US5922858 Misaminoacylated transfer ribonucleic acid with photocleavable marker; for incorporation of non-radioactive labels into nascent proteins by cellular or cell-free translation systems |
| 07/13/1999 | US5922854 Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids |
| 07/13/1999 | US5922853 Human pelota homolog |
| 07/13/1999 | US5922847 Exposure to antibody or fragments binding to epitope on receptor recognized by the factor, separating binding cells |
| 07/13/1999 | US5922846 Process for refolding recombinantly produced TGF-β-like proteins |
| 07/13/1999 | US5922845 Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies |
| 07/13/1999 | US5922844 Human cAMP-dependent protein kinase inhibitor homolog |
| 07/13/1999 | US5922841 Recombinantly produced transferrin receptor of haemophilus |
| 07/13/1999 | US5922839 Suppressing formation of angiotensin ii in mammals by administering mixture of dried stomach mucosa and acidifying agent to produce in situ pepsin-inhibitor peptide of 29 amino acids and molecular weight of 3242 daltons |
| 07/13/1999 | US5922838 Antitumor agents |
| 07/13/1999 | US5922837 Against malaria, toxoplasmosis, coccidiosis |
| 07/13/1999 | US5922836 Mammaglobin antigens |
| 07/13/1999 | US5922773 Treatment with n-methyl-d-aspartate antagonist for vision defects |
| 07/13/1999 | US5922765 Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength |
| 07/13/1999 | US5922763 Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/13/1999 | US5922688 Administering polyomavirus enhancer activator (pea3) to inhibit a transformed phenotype; treating neu-mediated cancer |
| 07/13/1999 | US5922686 Nucleotide sequences and hybridization and protein c and kinases |
| 07/13/1999 | US5922685 IL-12 gene therapy of tumors |
| 07/13/1999 | US5922681 Administering antagonists to treat asthma, hypertension, preeclampsia, myocardial infarction, diabetes, renal failure, septic shock, and other disease states associated with elevated levels of endothelin |
| 07/13/1999 | US5922680 Stabilized composition for oral administration of peptides |
| 07/13/1999 | US5922679 Use of α-conotoxin MII to treat disorders resulting from nicotine-stimulated dopamine release |
| 07/13/1999 | US5922678 Methionine-arginine or aspatartic acid modified leptins or proteins |
| 07/13/1999 | US5922677 Therapeutic method and compounds of use therein |
| 07/13/1999 | US5922676 Superfibronectin prevents tumor cell metastasis, tumor cell migration and growth by administering to the patient an effective amount of superfibronectin |
| 07/13/1999 | US5922675 A mixture of fatty acid amidated polypeptides and regular insulin for treating diabetes, use an extended duration of action |
| 07/13/1999 | US5922674 Inhibiting endothelial cell proliferation in a subject treated by with platinum coordination complex chemotherapeutic agent by simultaneous administration of erythropoietin |
| 07/13/1999 | US5922673 Method of treating hypertension in pregnant mammals |